BCHE and Lewy body dementia: Currently, there are no disease-modifying therapies for LBDs available (however, see [240]), although robust evidence supports the use of cholinesterase inhibitors (ChEIs) to treat these disorders [241, 242], related to the reduction of cholinergic markers in both PDD and DLB [243, 244].